Subtotal nephrectomy plus coronary ligation leads to more pronounced damage in both organs than either nephrectomy or coronary ligation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 3, 2012, Pages

  Bongartz, Lennart G ^a   Joles, Jaap A ^a   Verhaar, Marianne C ^a   Cramer, Maarten J ^a   Goldschmeding, Roel ^a   Tilburgs, Chantal ^a   Gaillard, Carlo A ^b   Doevendans, Pieter A ^a   Braam, Branko ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEANDER MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chronic kidney disease; Heart failure

Indexed keywords

CREATININE; NITRIC OXIDE; TAU PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FOLLOW UP; GLOMERULOSCLEROSIS; HEART DILATATION; HEART FAILURE; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; KIDNEY FUNCTION; MALE; MORTALITY; NEPHRECTOMY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; RELAXATION TIME; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ANIMALS; BLOOD PRESSURE; CARDIO-RENAL SYNDROME; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HEART FAILURE; LIGATION; MALE; MYOCARDITIS; NEPHRECTOMY; NEPHRITIS; NITRATES; NITRITES; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED LEW; RECEPTORS, CELL SURFACE; RENAL INSUFFICIENCY, CHRONIC; RENIN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TYROSINE;

EID: 84856423983     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00261.2011     Document Type: Article

References (58)

1. Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G. Reduced capillary density in the myocardium of uremic rats-a stereological study. Kidney Int 42: 1079-1085, 1992.
2. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295, 2004.
3. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glo-merular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619, 1985.
4. Attia DM, Ni ZN, Boer P, Attia MA, Goldschmeding R, Koomans HA, Vaziri ND, Joles JA. Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor incholesterol-fed rats. Kidney Int 61: 1776-1787, 2002.
5. Bauersachs J, Braun C, Fraccarollo D, Widder J, Ertl G, Schilling L, Kirchengast M, Rohmeiss P. Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252. J Hypertens 18: 1507-1514, 2000.
6. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 294: F1-F9, 2008.
7. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90: 278-281, 1992.
8. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, Mc-Cullough PA. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37: 1191-1200, 2001.
9. Bock JS, Gottlieb SS. Cardiorenal syndrome: new perspectives. Circulation 121: 2592-2600, 2010.
10. Bongartz LG, Braam B, Verhaar MC, Cramer MJ, Goldschmeding R, Gaillard CA, Doevendans PA, Joles JA. Transient nitric oxide reduction induces permanent cardiac systolic dysfunction and worsens kidney damage in rats with chronic kidney disease. Am J Physiol Regul Integr Comp Physiol 298: R815-R823, 2010.
11. Bongartz LG, Braam B, Verhaar MC, Cramer MJ, Goldschmeding R, Gaillard CA, Steendijk P, Doevendans PA, Joles JA. The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction. Am J Physiol Heart Circ Physiol 299: H2037-H2045, 2010.
12. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: "Guyton revisited." Eur Heart J 26: 11-17, 2005.
13. Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, Cleland JG, van Veldhuisen DJ, Hillege HL. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13: 599-608, 2007.
14. de Mattos AM, Siedlecki A, Gaston RS, Perry GJ, Julian BA, Kew CE, Deierhoi MH, Young C, Curtis JJ, Iskandrian AE. Systolic dysfunction portends increased mortality among those waiting for renal transplant. J Am Soc Nephrol 19: 1191-1196, 2008.
15. Dikow R, Kihm LP, Zeier M, Kapitza J, Tornig J, Amann K, Tiefenbacher C, Ritz E. Increased infarct size in uremic rats: reduced ischemia tolerance? J Am Soc Nephrol 15: 1530-1536, 2004.
16. Dikow R, Schmidt U, Kihm LP, Schaier M, Schwenger V, Gross ML, Katus HA, Zeier M, Hardt SE. Uremia aggravates left ventricular remodeling after myocardial infarction. Am J Nephrol 32: 13-22, 2010.
17. Eijkelkamp WB, de Graeff PA, van Veldhuisen DJ, van Dokkum RP, Gansevoort RT, de Jong PE, de Zeeuw D, Hillege HL. Effect of first myocardial ischemic event on renal function. Am J Cardiol 100: 7-12, 2007.
18. Elsayed EF, Tighiouart H, Griffith J, Kurth T, Levey AS, Salem D, Sarnak MJ, Weiner DE. Cardiovascular disease and subsequent kidney disease. Arch Intern Med 167: 1130-1136, 2007.
19. Fujihara CK, De Nucci G, Zatz R. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol 5: 1498-1507, 1995.
20. Gabbai FB, Thomson SC, Peterson O, Wead L, Malvey K, Blantz RC. Glomerular and tubular interactions between renal adrenergic activity and nitric oxide. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1004-F1008, 1995.
21. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 87: 755-763, 1993.
22. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.
23. Griffin KA, Picken MM, Churchill M, Churchill P, Bidani AK. Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat. J Am Soc Nephrol 11: 497-506, 2000.
24. Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol Heart Circ Physiol 267: H1804-H1813, 1994.
25. Hatori N, Havu N, Hofman-Bang C, Clyne N, Pehrsson SK. Myocar-dial morphology and cardiac function in rats with renal failure. Jpn Circ J 64: 606-610, 2000.
26. Hirose T, Mori N, Totsune K, Morimoto R, Maejima T, Kawamura T, Metoki H, Asayama K, Kikuya M, Ohkubo T, Kohzuki M, Takahashi K, Imai Y. Increased expression of (pro)renin receptor in the remnant kidneys of 5/6 nephrectomized rats. Regul Pept 159: 93-99, 2010.
27. Horstick G, Berg O, Heimann A, Darius H, Lehr HA, Bhakdi S, Kempski O, Meyer J. Surgical procedure affects physiological parameters in rat myocardial ischemia: need for mechanical ventilation. Am J Physiol Heart Circ Physiol 276: H472-H479, 1999.
28. Ichikawa I, Pfeffer JM, Pfeffer MA, Hostetter TH, Brenner BM. Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res 55: 669-675, 1984.
29. Ikenaga H, Ishii N, Didion SP, Zhang K, Cornish KG, Patel KP, Mayhan WG, Carmines PK. Suppressed impact of nitric oxide on renal arteriolar function in rats with chronic heart failure. Am J Physiol Renal Physiol 276: F79-F87, 1999.
30. Joles JA, Kunter U, Janssen U, Kriz W, Rabelink TJ, Koomans HA, Floege J. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 11: 669-683, 2000.
31. Joles JA, van Goor H, Koomans HA. Estrogen induces glomeruloscle-rosis in analbuminemic rats. Kidney Int 53: 862-868, 1998.
32. Kamijo H, Higuchi M, Hora K. Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats. Nephron Physiol 104: p12-p22, 2006.
33. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, Kahaleh MB, Xie Z, Malhotra D, Kolodkin NI, Lakatta EG, Fedorova OV, Bagrov AY, Shapiro JI. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic car-diomyopathy. Hypertension 47: 488-495, 2006.
34. Klabunde RE, Ritger RC, Helgren MC. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/ release in anesthetized dogs. Eur J Pharmacol 199: 51-59, 1991.
35. Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, Maeno T, Nishida T, Kubota S, Takigawa M, Kurabayashi M. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 49: 1120-1127, 2007.
36. Kojda G, Kottenberg K. Regulation of basal myocardial function by NO. Cardiovasc Res 41: 514-523, 1999.
37. Kompa AR, Summers RJ. Lidocaine and surgical modification reduces mortality in a rat model of cardiac failure induced by coronary artery ligation. J Pharmacol Toxicol Methods 43: 199-203, 2000.
38. Latouche C, Sainte-Marie Y, Steenman M, Castro Chaves P, Naray-Fejes-Toth A, Fejes-Toth G, Farman N, Jaisser F. Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart. Endocrinology 151: 4467-4476, 2010.
39. Matter CM, Mandinov L, Kaufmann PA, Vassalli G, Jiang Z, Hess OM. Effect of NO donors on LV diastolic function in patients with severe pressure-overload hypertrophy. Circulation 99: 2396-2401, 1999.
40. Moreno H Jr, Metze K, Bento AC, Antunes E, Zatz R, de Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res Cardiol 91: 248-255, 1996.
41. Naito K, Anzai T, Yoshikawa T, Anzai A, Kaneko H, Kohno T, Takahashi T, Kawamura A, Ogawa S. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling. J Card Fail 14: 831-838, 2008.
42. Nolan SE, Mannisi JA, Bush DE, Healy B, Weisman HF. Increased afterload aggravates infarct expansion after acute myocardial infarction. J Am Coll Cardiol 12: 1318-1325, 1988.
43. Patzak A, Kleinmann F, Lai EY, Kupsch E, Skelweit A, Mrowka R. Nitric oxide counteracts angiotensin II induced contraction in efferent arterioles in mice. Acta Physiol Scand 181: 439-444, 2004.
44. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89: 2070- 2078, 1994.
45. Rasband WS. ImageJ (1.6 edition). Bethesda, MD: U.S. National Institutes of Health, 1997-2010.
46. Reddy V, Bhandari S, Seymour AM. Myocardial function, energy provision, and carnitine deficiency in experimental uremia. J Am Soc Nephrol 18: 84-92, 2007.
47. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bag-shaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J 31: 703-711, 2010.
48. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospi-talizations. J Am Coll Cardiol 35: 1737-1744, 2000.
49. Smilde TD, Damman K, van der Harst P, Navis G, Daan Westenbrink B, Voors AA, Boomsma F, van Veldhuisen DJ, Hillege HL. Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Clin Res Cardiol 98: 121-129, 2009.
50. Tian J, Shidyak A, Periyasamy SM, Haller S, Taleb M, El-Okdi N, Elkareh J, Gupta S, Gohara S, Fedorova OV, Cooper CJ, Xie Z, Malhotra D, Bagrov AY, Shapiro JI. Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin. Hypertension 54: 1313-1320, 2009.
51. van Dokkum RP, Eijkelkamp WB, Kluppel AC, Henning RH, van Goor H, Citgez M, Windt WA, van Veldhuisen DJ, de Graeff PA, de Zeeuw D. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J Am Soc Nephrol 15: 3103-3110, 2004.
52. Varma SK, Owen RM, Smucker ML, Feldman MD. Is tau a preload-independent measure of isovolumetric relaxation? Circulation 80: 1757-1765, 1989.
53. Velkoska E, Dean RG, Burchill L, Levidiotis V, Burrell LM. Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition. Clin Sci (Lond) 118: 269-279, 2010.
54. Verhagen AM, Braam B, Boer P, Grone HJ, Koomans HA, Joles JA. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations. Kidney Int 56: 222-231, 1999.
55. Verma A, Anavekar NS, Meris A, Thune JJ, Arnold JM, Ghali JK, Velazquez EJ, McMurray JJ, Pfeffer MA, Solomon SD. The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study. J Am Coll Cardiol 50: 1238-1245, 2007.
56. Wesseling S, Koeners MP, Kantouh F, Joles JA, Braam B. Consequences of perinatal treatment with L-arginine and antioxidants for the renal transcriptome in spontaneously hypertensive rats. Pflugers Arch 458: 513-524, 2009.
57. Windt WA, Henning RH, Kluppel AC, Xu Y, de Zeeuw D, van Dokkum RP. Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats. Nephrol Dial Transplant 23: 3103-3110, 2008.
58. Xu J, Zhang C, Khanna A. Wideband high-frequency echocardiography to evaluate myocardial infarct size. J Ultrasound Med 28: 1527-1534, 2009.